Tag: clinical trials

Common Deficiencies in Pharmacy Manual, Lab Manual, Imaging Manual Highlighted in FDA, EMA and MHRA Inspections

Posted on By digi

Common Deficiencies in Pharmacy Manual, Lab Manual, Imaging Manual Highlighted in FDA, EMA and MHRA Inspections Introduction to Clinical Trial Documentation Standards In the context of conducting a prima clinical trial, the establishment and adherence to robust documentation standards is paramount. Regulatory agencies such as the FDA, EMA, and MHRA require comprehensive and precise documentation…

Read More “Common Deficiencies in Pharmacy Manual, Lab Manual, Imaging Manual Highlighted in FDA, EMA and MHRA Inspections” »

Pharmacy Manual, Lab Manual, Imaging Manual

Timelines and Content Requirements for Serious Breach Notifications

Posted on By digi

Timelines and Content Requirements for Serious Breach Notifications In the evolving landscape of clinical trials, particularly biosimilar clinical trials, maintaining compliance with regulatory frameworks is paramount. Serious breaches, or deviations from established protocols and guidelines, can significantly impact the integrity of clinical research outcomes and the safety of participants. This article serves as a comprehensive…

Read More “Timelines and Content Requirements for Serious Breach Notifications” »

Regulatory Notifications & IRB Reporting

Aligning Sponsor, CRO and Site SOPs on Deviation Reporting to Regulators

Posted on By digi

Aligning Sponsor, CRO and Site SOPs on Deviation Reporting to Regulators Aligning Sponsor, CRO and Site SOPs on Deviation Reporting to Regulators In the landscape of clinical trials, effectively navigating regulatory requirements is crucial for sponsors, Contract Research Organizations (CROs), and clinical trial sites. One of the most critical aspects of clinical trial management revolves…

Read More “Aligning Sponsor, CRO and Site SOPs on Deviation Reporting to Regulators” »

Regulatory Notifications & IRB Reporting

Aligning Sponsor Transparency Governance With ICH, GCP and Transparency Regulations

Posted on By digi

Aligning Sponsor Transparency Governance With ICH, GCP and Transparency Regulations Aligning Sponsor Transparency Governance With ICH, GCP and Transparency Regulations Introduction The regulatory landscape surrounding clinical trials continues to evolve, emphasizing the necessity for sponsors to maintain a robust governance framework surrounding transparency. This step-by-step guide aims to provide clinical operations, regulatory affairs, and medical…

Read More “Aligning Sponsor Transparency Governance With ICH, GCP and Transparency Regulations” »

Sponsor Transparency Governance

Sponsor Transparency Governance Playbook for High-Profile and Late-Phase Trials

Posted on By digi

Sponsor Transparency Governance Playbook for High-Profile and Late-Phase Trials Sponsor Transparency Governance Playbook for High-Profile and Late-Phase Trials Understanding the Importance of Sponsor Transparency in Clinical Trials Sponsor transparency in clinical trials is essential for maintaining the integrity of clinical research and ensuring that stakeholders, including patients, regulators, and the wider community, are adequately informed….

Read More “Sponsor Transparency Governance Playbook for High-Profile and Late-Phase Trials” »

Sponsor Transparency Governance

Pharmacy Manual, Lab Manual, Imaging Manual in Practice: Step-by-Step Guide for Sponsors, CROs and Sites

Posted on By digi

Pharmacy Manual, Lab Manual, Imaging Manual in Practice: Step-by-Step Guide for Sponsors, CROs and Sites Pharmacy Manual, Lab Manual, Imaging Manual in Practice: Step-by-Step Guide for Sponsors, CROs and Sites In the rapidly evolving landscape of clinical research, a structured approach to documentation and operational protocols is paramount. This comprehensive guide offers a step-by-step tutorial…

Read More “Pharmacy Manual, Lab Manual, Imaging Manual in Practice: Step-by-Step Guide for Sponsors, CROs and Sites” »

Pharmacy Manual, Lab Manual, Imaging Manual

IRB/IEC Reporting Thresholds for Deviations That Impact Safety or Rights

Posted on By digi

IRB/IEC Reporting Thresholds for Deviations That Impact Safety or Rights IRB/IEC Reporting Thresholds for Deviations That Impact Safety or Rights Introduction to IRB/IEC Reporting in Clinical Trials In clinical research, oversight by institutional review boards (IRBs) or ethics committees (IECs) is paramount for protecting the rights and welfare of participants. This article aims to provide…

Read More “IRB/IEC Reporting Thresholds for Deviations That Impact Safety or Rights” »

Regulatory Notifications & IRB Reporting

Coordinating Notifications Across FDA, EMA, MHRA and Local Ethics Bodies

Posted on By digi

Coordinating Notifications Across FDA, EMA, MHRA and Local Ethics Bodies In the complex landscape of clinical trials, ensuring compliance with various regulatory bodies is critical for maintaining the integrity and success of a study. This article provides a detailed, step-by-step tutorial for clinical operations, regulatory affairs, and medical affairs professionals on coordinating notifications across the…

Read More “Coordinating Notifications Across FDA, EMA, MHRA and Local Ethics Bodies” »

Regulatory Notifications & IRB Reporting

Sponsor Transparency Governance in Practice: Step-by-Step Guide for Sponsors and CROs

Posted on By digi

Sponsor Transparency Governance in Practice: Step-by-Step Guide for Sponsors and CROs Sponsor Transparency Governance in Practice: Step-by-Step Guide for Sponsors and CROs Introduction to Sponsor Transparency Governance Sponsor transparency governance has emerged as a critical aspect of clinical trial management, especially for schizophrenia clinical trials. The increasing expectations from regulatory authorities and stakeholders placed upon…

Read More “Sponsor Transparency Governance in Practice: Step-by-Step Guide for Sponsors and CROs” »

Sponsor Transparency Governance

Common Pitfalls in Sponsor Transparency Governance—and How to Avoid Costly Findings

Posted on By digi

Common Pitfalls in Sponsor Transparency Governance—and How to Avoid Costly Findings Common Pitfalls in Sponsor Transparency Governance—and How to Avoid Costly Findings Effective governance in clinical trials is paramount for ensuring compliance with regulatory standards and safeguarding patient interests. This tutorial provides a comprehensive guide for clinical operations, regulatory affairs, and medical affairs professionals to…

Read More “Common Pitfalls in Sponsor Transparency Governance—and How to Avoid Costly Findings” »

Sponsor Transparency Governance